Join us this Thursday, 2/27, for an exciting look at the next generation of blood-based predictive biomarkers for therapy selection.

Warning Signs From The Crypt: Circulating Aberrant Glycosylation Signatures Detect Advanced Adenoma And Colorectal Cancer

Get in touch